Venu R. Gurijala

Statistics

Publications

Citations

123

H-Index

Active since

2021

Affiliations

Mersana Therapeutics (United States)(Current)

Venu R. Gurijala is an author at Mersana Therapeutics (United States) specializing in antibody-drug conjugates, antibody-drug conjugate therapy, and pharmacology.

Publications per year

2021–2021

Publications

Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect

Aleksandr V. Yurkovetskiy, Natalya D. Bodyak, Mao Yin et al. · Molecular Cancer Therapeutics · 2021 · 75 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b

Natalya D. Bodyak, Rebecca Mosher, Aleksandr V. Yurkovetskiy et al. · Molecular Cancer Therapeutics · 2021 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2